Skip to content

Prostate nodule: is it cancer?

What a nodule on rectal exam, ultrasound or MRI can be, and the path to a diagnosis.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 18, 2026
Book a consultation
Drawing of the prostate in cross-section, seen from above, with the rectum below and three different findings, a round layered benign nodule in the centre of the gland, a group of white calcifications near the urethra and a purple area at the back, next to the rectum
On this page

Quick answer

A prostate nodule can be benign growth, inflammation, a calcification or cancer. When the rectal exam is suspicious and the PSA is 4 ng/mL or less, the biopsy shows cancer in 5% to 30% of cases.1 Standard ultrasound is not reliable for detecting cancer, and the test that guides the decision is the MRI.1 In my practice, an abnormal rectal exam always leads to an MRI, even with a normal PSA, and PI-RADS 3 or higher always leads to a biopsy.

Where the nodule shows up

The word nodule appears in three different tests, and each carries a different weight:

  • On rectal exam: the urologist feels a harder area or a bump at the back of the prostate. This is the region the finger can reach, and it is there, in the peripheral zone, that most tumors start. In a classic series of removed prostates, 68% of cancers had begun in this zone.5
  • On ultrasound: the report describes an area darker or brighter than the rest of the gland.
  • On MRI: the radiologist describes the suspicious area as a lesion and gives it a score from 1 to 5, the PI-RADS.3

A nodule on rectal exam

The rectal exam is still useful. In about 18% of cases, cancer is found only because of an abnormal rectal exam, whatever the PSA level.1 When the PSA is 4 ng/mL or less, a suspicious rectal exam shows cancer on biopsy 5% to 30% of the time.1

In the European guideline, an abnormal rectal exam is an indication for an MRI or, when the tumor seems to have grown beyond the prostate, for a direct biopsy.1 In my practice, with an abnormal rectal exam, I always order an MRI, even when the PSA is normal.

A nodule on ultrasound

Many men first read about a nodule in an ultrasound report. The European guideline states that standard transrectal ultrasound is not reliable for detecting prostate cancer. Extra biopsies of dark areas on ultrasound, called hypoechoic, add almost no diagnoses.1

So ultrasound alone does not decide on a biopsy. The next step is an MRI, and the ultrasound report is read together with the PSA and the rectal exam.

A lesion on MRI

On MRI, each suspicious area gets a PI-RADS score. The higher the score, the higher the chance of clinically significant cancer.3 In a review of 117 studies, it was found in 20% of men with PI-RADS 3, 53% with PI-RADS 4 and 83% with PI-RADS 5.4 The page PI-RADS 3, 4 or 5 explains each score.

MRI finds more significant tumors than a biopsy guided by ultrasound alone. In the PROMIS study, it found 93% of them, and the ultrasound-guided biopsy 48%.8 In the PRECISION trial, MRI with targeted biopsy found significant cancer in 38% of men, compared with 26% with standard biopsy.9

What it can be besides cancer

Several benign findings can be called a nodule:

  • Benign growth (BPH): the enlarged prostate forms nodules in the transition zone, the central part around the urethra. On MRI, a typical BPH nodule is round and completely encapsulated, and it gets the lowest PI-RADS score.3 The page on the enlarged prostate explains this growth.
  • Prostatitis: in acute inflammation, the prostate can feel swollen and tender on rectal exam, and the PSA rises in about 60% of men.2 On MRI, some benign conditions look very similar to cancer.1
  • Calcifications: small calcium deposits, very common. In a Korean study of 479 men, 41.5% had prostate calcifications.6 In an English series of men about to have a biopsy, the most common type, along the border between the transition and peripheral zones, was not linked to any diagnosis. Calcification within the peripheral zone was rare, in 6.8% of men, and was more often associated with cancer.7

The path to a diagnosis

In my practice, the workup follows these steps:

  1. Abnormal rectal exam or raised PSA: a prostate MRI. With a raised PSA, I go straight to the MRI, without repeating the PSA first.
  2. PI-RADS 3, 4 or 5: I always recommend a biopsy.
  3. PI-RADS 1 or 2: I look at the PSA density, calculated from the prostate volume, together with the other findings. The European guideline accepts skipping the biopsy when the PI-RADS is 2 or lower, the density is below 0.20 ng/mL/cc and there is no family history of prostate cancer.1

The biopsy is done by the transperineal route, in the operating room, always under sedation. It takes about 20 minutes, without antibiotics. Where I work, the needle targets the MRI lesion by cognitive fusion: I study the images and locate the lesion on ultrasound during the procedure.

How I approach it

At the consultation, I review the PSA, the ultrasound and MRI reports and your family history, and examine the prostate when we meet in person. I explain what the nodule could be and what the next step is in your case.

I have a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic.

When to see a urologist

  • If a doctor felt a nodule or a hard area on rectal exam
  • If an ultrasound or MRI report described a nodule or a lesion in the prostate
  • If your PSA is raised, even without a nodule

Send your case

If you are looking into a prostate nodule, with an abnormal rectal exam, ultrasound, MRI or PSA, and would like my opinion before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Is a prostate nodule cancer?

Not always. A nodule is the name of a finding, and it can be benign growth, inflammation, a calcification or cancer. When the rectal exam is suspicious and the PSA is 4 ng/mL or less, the biopsy shows cancer in 5% to 30% of cases.1 The workup, with MRI and, when indicated, a biopsy, tells them apart.

What happens when a nodule is felt on rectal exam?

In the European guideline, an abnormal rectal exam is an indication for a prostate MRI or, when the tumor seems to have grown beyond the prostate, for a direct biopsy.1 In my practice, with an abnormal rectal exam, I always order an MRI, even when the PSA is normal.

Can a nodule be cancer even with a normal PSA?

Yes. In about 18% of cases, prostate cancer is found only because of an abnormal rectal exam, whatever the PSA level.1 That is why a nodule on rectal exam deserves investigation even when the PSA is normal.

Is a nodule on prostate ultrasound cancer?

Ultrasound alone cannot answer that question. The European guideline states that standard transrectal ultrasound is not reliable for detecting prostate cancer and that extra biopsies of dark areas on ultrasound add almost no diagnoses.1 The test that guides the biopsy decision is the MRI.

Is a PI-RADS lesion on MRI the same as a nodule?

It is how the MRI describes a suspicious area, with a score from 1 to 5.3 In a review of 117 studies, significant cancer was found in 20% of men with PI-RADS 3, 53% with PI-RADS 4 and 83% with PI-RADS 5.4 In my practice, with PI-RADS 3 or higher, I always recommend a biopsy.

Are prostate calcifications dangerous?

Most of the time, no. In a Korean study of 479 men who had an ultrasound, 41.5% had prostate calcifications.6 In an English series of men about to have a biopsy, the most common type, along the border between the transition and peripheral zones, was not linked to any diagnosis. Calcification within the peripheral zone was rare, at 6.8%, and was more often associated with cancer.7

What is the biopsy like when a nodule is suspicious?

In my practice, since 2022, the biopsy is done by the transperineal route, in the operating room, always under sedation. It takes about 20 minutes, is done without antibiotics and targets the lesion seen on MRI.

Who can assess a prostate nodule in São Paulo?

I assess men with a nodule on rectal exam, ultrasound or MRI. I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, Brazil, with a PhD from the University of São Paulo Medical School and award-winning research on artificial intelligence in prostate cancer diagnosis. I have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic. The first consultation can be online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: diagnostic evaluation. European Association of Urology; 2026. EAU
  2. EAU Guidelines on Urological Infections. European Association of Urology; 2026. Section on bacterial prostatitis. EAU
  3. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76(3):340-351. PubMed
  4. Nedelcu A, Oerther B, Benkendorff A, et al. PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics. AJR Am J Roentgenol. 2026;226(2):e2533583. PubMed
  5. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897-906. PubMed
  6. Hong CG, Yoon BI, Choe HS, et al. The Prevalence and Characteristic Differences in Prostatic Calcification between Health Promotion Center and Urology Department Outpatients. Korean J Urol. 2012;53(5):330-334. PubMed
  7. Smolski M, Turo R, Whiteside S, Bromage S, Collins GN. Prevalence of prostatic calcification subtypes and association with prostate cancer. Urology. 2015;85(1):178-181. PubMed
  8. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815-822. PubMed
  9. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378(19):1767-1777. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides